Skip to main content
Caplight Logo









gaitQ

gaitQ

Private
OxfordHealthcare & Life Scienceshttps://gaitq.com

Last Round

Grant

Apr 11, 2024

Total Funding Raised

$2.06M

Company Overview

gaitQ operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Grant round in April 2024.

gaitQ is a medical technology company that develops wearable devices designed to help people with Parkinson's disease overcome gait freezing and improve mobility.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

gaitQ Comparables

Compare gaitQ with similar companies based on industry and business-model similarity.

gaitQ comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Walk With Path
88%
Charco Neurotech
88%
Lifespark Technologies
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

gaitQ Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 11, 2024
GrantMar 29, 2021
Pre SeedFeb 9, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Tristan Collins

Chief Executive Officer

Executive Team

Katherine Woodrow

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

gaitQ Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 10, 2024

    Grew 19% QoQ from 16 to 19 employees.

  • Apr 11, 2024

    Secured $1M from Innosuisse and Innovate UK.

Book a demo to see all signals

For institutional investors. Book with your work email.

gaitQ Filings

Explore SEC and related filing metadata, where available.

gaitQ filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about gaitQ's valuation, stock price, and market status.

Is gaitQ a public or private company?

gaitQ is a private company.

What is the current stock price of gaitQ?

gaitQ is a private company, so its shares have no public market price. Caplight tracks gaitQ's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is gaitQ worth (valuation)?

Valuation information for gaitQ is not publicly available.

Can I buy gaitQ stock?

gaitQ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was gaitQ's last funding round?

gaitQ's most recent funding round was Grant on April 11, 2024.

Who are the main investors in gaitQ?

Key investors in gaitQ include Innovate UK, Innosuisse, National Institute for Health and Care Research, Parkwalk Advisors.

Will gaitQ IPO soon?

No public IPO plans have been announced for gaitQ.

How can I track gaitQ secondary market activity?

Caplight tracks bids, offers, and trades in gaitQ's shares on secondary markets.

Firmographic Details

HeadquartersOxford
Employee Range11
Year Founded2019
Last FundingApr 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?